These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3165308)

  • 21. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years' seropositivity.
    Gunduz T; Mumcuoglu I; Güray M
    Int J Clin Pharmacol Res; 2005; 25(3):155-8. PubMed ID: 16366424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonparenteral transmission of viral hepatitis in Greece.
    Hadziyannis SJ
    Am J Med Sci; 1975; 270(2):313-8. PubMed ID: 1235473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of antibodies against human immunodeficiency virus (HIV) and other infectious disease markers in blood donors from the city of Puebla].
    Marín López A
    Rev Invest Clin; 1987; 39(3):219-22. PubMed ID: 3481100
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of anti-HIV and anti-delta among deferred HBsAg-positive volunteer blood donors.
    deMedina MD; Jeffers LJ; Reddy KR; Villanueva SY; Brendal W; Lenes B; Tomasulo P; Schiff ER
    Ann Intern Med; 1987 Aug; 107(2):256-7. PubMed ID: 3474916
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevalence of HIV and HBs antigen in blood donors. Residual risk of contamination in blood recipients in East Kinshasa, Democratic Republic of the Congo].
    Mbendi Nlombi C; Longo-Mbenza B; Mbendi Nsukini S; Muyembe Tamfum JJ; Situakibanza Nanituma H; Vangu Ngoma D
    Med Trop (Mars); 2001; 61(2):139-42. PubMed ID: 11582869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis and hepatitis B surface antigen and antibody in dentists.
    Berris B; Feinman SV; Sinclair JC; Wrobel D
    Can Med Assoc J; 1978 Nov; 119(9):1040-3. PubMed ID: 743666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in HBs antigen and anti-HBs antibody in 77 patients with acute B-virus hepatitis].
    Molinié C; Saliou P; Laverdant C; Roué R; Vergeau B; Denée JM; de Bourayne J; Bonnet D
    Gastroenterol Clin Biol; 1984 Feb; 8(2):109-15. PubMed ID: 6698349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico].
    Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A
    Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frequency of HBs antigens and anti-HBc, anti-CMV and anti-HTLV antibodies in 76 hemodialysis patients].
    Chouikha M; Bahri M; Amor A; Nooman S
    Tunis Med; 1987; 65(8-9):575-6. PubMed ID: 2849823
    [No Abstract]   [Full Text] [Related]  

  • 33. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
    Zawde D; Sisay Y
    Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carriage of HBs antigen and infection by delta agent in Cameroon].
    Poveda JD; Delord B; Chancerel B; Bailly C; Merlin M; Le Bras M; Fleury HJ
    Bull Soc Pathol Exot Filiales; 1986; 79(5 Pt 2):785-7. PubMed ID: 3829218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Incidence of HBs Ag and anti-HBs measured by countercurrent discontinuous immunoelectrophoresis (C-IEP)].
    Duca M; Colev A; Caraman D; Vîrnă G; Marinescu C
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(1):59-63. PubMed ID: 866839
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Virologic considerations in donor selection for allogeneic keratoplasty].
    Bialasiewicz AA; Naumann GO; Jahn GJ
    Klin Monbl Augenheilkd; 1988 Jun; 192(6):634-6. PubMed ID: 3062243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 39. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.